文献速递头颈外科

大麻使用与新诊断头颈癌患者心理社会及生活质量结局的关联

Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2018-01-01

这项前瞻性病例匹配研究纳入148例新诊断头颈癌患者,按年龄、性别和肿瘤亚部位1:1匹配74例大麻使用者与74例非使用者。大麻使用者在EQ5D的焦虑/抑郁和疼痛/不适维度得分显著更低,ESAS显示疼痛、疲乏、抑郁、焦虑、嗜睡更轻,食欲和总体健康状况更好。

要点

  • 新诊断头颈癌患者中,大麻使用与焦虑、抑郁和疼痛评分显著改善相关。
  • 大麻使用者报告食欲增加、疲乏和嗜睡减轻及总体健康状况更好。
  • EQ5D中移动、自理和日常活动维度两组无显著差异。

核心结论

  • 新诊断头颈癌患者中,大麻使用可能与显著的生活质量获益相关,包括焦虑、疼痛和抑郁减轻以及食欲和总体健康感增加。

研究设计与样本

  • 前瞻性队列研究,在三级癌症中心连续入组2011年1月1日至2015年1月1日新诊断的头颈癌患者。
  • 74例当前大麻使用者按年龄、性别和肿瘤亚部位1:1病例匹配74例非使用者,共148例。

主要发现

  • EQ5D中移动、自理和日常活动维度两组无统计学显著差异。
  • 大麻使用者在EQ5D焦虑/抑郁维度得分差异为0.74(95%CI 0.557-0.930),疼痛/不适维度差异为0.29(95%CI 0.037-1.541)。
  • Wilcoxon秩和检验证实EQ5D疼痛/不适(z=-2.60)和焦虑/抑郁(z=-6.71)维度改善。
  • ESAS显示大麻使用者疼痛、疲乏、抑郁、焦虑、嗜睡更轻,食欲和总体健康状况更好。
  • Wilcoxon秩和检验证实ESAS焦虑(z=-10.04)、疼痛(z=-2.36)、疲乏(z=-5.02)、抑郁(z=-5.96)、嗜睡(z=-5.51)、食欲(z=-4.17)和总体健康(z=-4.43)维度显著改善。

临床怎么用

  • 在评估新诊断头颈癌患者的生活质量和心理社会问题时,应考虑询问大麻使用情况。
  • 大麻使用可能与焦虑、抑郁、疼痛、食欲及总体健康感等患者报告结局的改善相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cannabis sativa, the most widely used illicit substance in Canada, has a unique ability to facilitate relaxation and relieve anxiety while reducing pain. However, no study to date has examined quality of life (QOL) and psychosocial issues in relation to the use of this drug among patients with newly diagnosed head and neck cancer (HNC). OBJECTIVE: To examine the differences in QOL and psychosocial outcomes between marijuana users and nonusers with newly diagnosed HNC. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted at a tertiary care cancer center. Patients were enrolled consecutively and prospectively at the time of HNC diagnosis from January 1, 2011, to January 1, 2015. Seventy-four patients who were current marijuana users were case matched to 74 nonusers in a 1:1 scheme based on age, sex, and tumor subsite. All patient demographic and QOL data were collected prospectively, and data analysis was conducted from November 1 to December 1, 2017. MAIN OUTCOMES AND MEASURE: The QOL outcome was assessed using the EuroQol-5D (EQ5D) and the Edmonton Symptom Assessment System (ESAS) questionnaires. RESULTS: A total of 148 patients were included in this study: 74 in the marijuana user group (mean [SD] age, 62.3 [10.3] years; male sex, 61 patients [82%]) and 74 in the marijuana nonuser group (mean age, 62.2 years; male sex, 63 patients [85%]). There was no statistically significant difference in age, sex, tumor subsite, clinical TNM staging, treatment modality, or mean Karnofsky score between the 2 groups. On univariate analysis, there was no statistically significant difference in the mobility, self-care, and usual activities domains of the EQ5D. Marijuana users had significantly lower scores in the anxiety/depression (difference, 0.74; 95% CI, 0.557-0.930) and pain/discomfort (difference, 0.29; 95% CI, 0.037-1.541) domains. Wilcoxon rank sum test confirmed the results of the EQ5D with improvements in the pain/discomfort (z score, -2.60) and anxiety/depression (z score, -6.71) domains. Marijuana users had less pain, were less tired, were less depressed, were less anxious, had more appetite, were less drowsy, and had better general well-being according to the ESAS. A Wilcoxon rank sum test confirmed a statistically significant improvement in ESAS scores within the domains of anxiety (z score, -10.04), pain (z score, -2.36), tiredness (z score, -5.02), depression (z score, -5.96), drowsiness (z score, -5.51), appetite (z score, -4.17), and general well-being (z score, -4.43). CONCLUSIONS AND RELEVANCE: This prospective case-matched study suggests that there may be significant QOL benefits, including decreased anxiety, pain, and depression and increased appetite and generalized feelings of well-being, associated with marijuana use among patients with newly diagnosed HNC.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Zhang H, Xie M, Archibald SD, et al. Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30073295. doi:10.1001/jamaoto.2018.0486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。